Evaluate the Pharmacokinetics of Oral Arsenic Trioxide Solution Under Fasting and Fed Conditions, to Compare Intravenous Arsenic Trioxide, in Acute Promyelocytic Leukemia
Clinical trial NCT06882031 · COMPLETED
Trial details
- NCT number
- NCT06882031
- Sponsor
- SDK Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-11
- Primary completion
- 2025-06-25
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.